To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Teresa Neumann/News Release : Jan 5, 2011  PR Newswire/Veridex

"There's a lot of potential here, and that's why there's a lot of excitement."

(Raritan, NJ)—Several news agencies this week have reported on an AP story about a "revolutionary" blood test that can spot a single cancer cell among millions of healthy ones. Since four large cancer centers will be using it in studies, and Johnson & Johnson has decided to bring it to the market, it signals great hope for early detection of the disease.

Notes excerpts from a PR Newswire release about the test, coined the CellSearch system: Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast cancer (MBC), according to a newly published report in the July 10, 2010 issue of the Journal of Clinical Oncology. The CellSearch(R) System is the first 510(k) diagnostic test used to automate the capture and detection of CTCs, tumor cells that have detached from solid tumors and entered the patient's blood. (Photo by: Griszka Niewiadomski)

"Measuring CTCs in metastatic breast cancer patients provides oncologists with an additional tool to help us better monitor patient outcomes," said one of the lead authors, Dr. Massimo Cristofanilli, associate professor in the Department of Breast Medical Oncology at The University of Texas M. D. Anderson Cancer Center. "The CellSearch(R) CTC test provides an early indication about patients' disease progression and overall survival."

CTCs and FDG-PET/CT are two of the most promising new tools for therapeutic monitoring in patients with MBC. The number of CTCs identified in patients with MBC is related to patient prognosis; a high number of CTCs at any time during treatment is associated with poor prognosis.

The CellSearch(R) test works by using antibodies that are joined to microscopic iron particles, called ferrofluid. These antibody/ferrofluid combinations attach very specifically to CTCs. Powerful magnets then draw the CTCs out of the blood sample and they are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Christopher Columbus and the Birth of the Modern World

Trump: Zacharia Will Start Term as Press Secretary on Monday

Elon Musk's Starlink Set to Become a ‘Major Mobile Carrier'

Tens of Thousands of Illegal Votes Could be Cast in Georgia, Analyst Warns

Teachers Union Blocks Feds From Finding Fraudulent School Bus Drivers

Authorities Dismantle Louisiana Medicaid Fraud Web of Islamic Terror Financiers

First Atlantic Hurricane of 2026 Kills 4; Knocks Out Power for Nearly 1 Million

Saudi Arabia Faces Fresh Attacks as Deadly Houthi Strikes Keep Riyadh Airport Closed

Federal Agents Raid Rep. Ilhan Omar's DC Home

Researcher Convinced He's Found Noah's Ark Delivers a Message for Critics

Roseanne Barr Is Coming Back With a New Family Series

Security Bite: Apple's Latest Update, iOS 27, Lets Apps Ask Your iPhone If You're Being Scammed

When Death is Dressed as a Cure

Democrat Socialist Policies Would Cost $350K Per Household, Shorten Life Expectancy, Report Finds

Texas County Takes Stand Against Sharia With Unanimous Vote

New California Law Forces Churches to Provide 'Hate Speech' Training

First Atlantic Hurricane of the Season, Isaias Strengthens into Category 3 Storm, Threatens Gulf Coast

Massive 2,000-Year-Old Discovery Brings the World of Jesus to Life

Remembering October 7th: Thousands of Christians Gather in Jerusalem to Fight 'Spiritual Battle'

Pro-Lifers Visit Millions of Homes in Battleground States Ahead of Midterms

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor